Publications

Jan 1, 2021 Mol Cell Proteomics.

Allele-specific thresholds of eluted ligands for T-cell epitope prediction.

Reardon B, Koşaloğlu-Yalçın Z, Paul S, Peters B, Sette A.

Jan 1, 2021 FASEB J.

Human rhinovirus-specific CD8 T cell responses target conserved and unusual epitopes.

Gomez-Perosanz M, Sanchez-Trincado JL, Fernandez-Arquero M, Sidney J, Sette A, Lafuente EM, Reche PA.

Jan 1, 2021 Mov Disord.

Inflammation in experimental models of α-synucleinopathies.

Harms AS, Kordower JH, Sette A, Lindestam Arlehamn CS, Sulzer D, Mach RH.

Jan 1, 2021 Cytokine.

Lack of evidence supporting a role of IFN-β and TGF-β in differential polarization of Bordetella pertussis specific-T cell responses.

da Silva Antunes R, Quiambao LG, Soldevila F, Sutherland A, Peters B, Sette A.

Jan 1, 2021 J Thorac Oncol.

HLA class I binding of mutant EGFR peptides in NSCLC Is associated with improved survival.

Dimou A, Grewe P, Sidney J, Sette A, Norman PJ, Doebele RC.

Dec 9, 2020 bioRxiv

Comprehensive analysis of T cell immunodominace and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases

Tarke, A., Sidney, J., Kidd, C.K., Dan, J.M., Ramirez, S.I., Yu, E.D., Mateus, J., da Silva Antunes, R., Moore, E., Rubiro, P., Methot, N., Phillips, E., Mallal, S., Frazier, A., Rawlings, S.A., Greenbaum, J.A., Peters, B., Smith, D.M., Crotty, S., Weiskopf, D., Grifoni, A., and Sette, A.

Dec 8, 2020 Lancet Respir Med

Safety and immunogenicity of the adjunct therapeutic vaccine ID93+ GLA-SE in adult who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial

Day, T.A., Penn-Nicholson, A., Luabeya, A.K.K., Fiore-Gartland, A., Du Plessis, N., Loxton, A.G., Vergara, J., Rolf, T.A., Reid, T.D., Toefy, A., Shenje, J., Geldenhuys, H., Tameris, M., Mabew, S., Bilek, N., Bekker, L.G., Diacon, A., Walzl, G., Ashman, J., Frevol, A., Sagawa, Z.K., Lindestam Arlehamn, C., Sette, A., Reed, S.G., Coler, R.N., Scriba, T.J., Hatherill, M.; TBVPX-203 study team

Nov 24, 2020 Sci Rep

Conserved epitopes with high HLA-1 population coverage are targets of CD8+ T cells associated with high IFN-g resposes against all dengue virus serotypes

Adikari, T.N., Di Giallonardo, F., Leung, P., Grifoni, A., Sette, A., Weiskopf, D., Bull, R.A., and Luciani, F.

Nov 20, 2020 Front Immunol

Case Report: Convalescent plasma, a targeted therapy for patients with CVID and severe COVID-19

Van Damme, K.F.A., Tavernier, S., Van Roy, N., De Leeuw, E., Declercq, J., Bosteels, C., Maes, B., De Bruyne, M., Bogaert, D., Bosteels, V., Hoste, L., Naesens, L., Maes, P., Grifoni, A., Weiskopf, D., Sette, A., Depuydt, P., Van Braeckel, E., Haerynck, F., and Lambrecht, B.N.

Nov 12, 2020 Viruses

Identification of novel yellow fever class II epitopes in YF-17D vaccines

Mateus, J., Grifoni, A., Voic, H., Angelo, M.A., Phillips, E., Mallel, S., Sidney, J., Sette, A.*, and Weiskopf, D.

Nov 10, 2020 Proc Natl Acad Sci USA

HLA tapasin independence: broader peptide repertoire and HIV control

Bashirova, A.A., Viard, M., Naranbhai, V., Grifoni, A., Garcia-Belran, W., Akdag, M., Yuki, Y., Gao, X., O’hUigin, C., Raghavan, M., Wolinsky, S., Bream, J.H., Duggal, P., Martinson, J., Michael, N.L., Kirk, G.D., Buchbinder, S.P., Haas, D., Goedert, J.J., Deeks, S.G., Fellary, J., Walker, B., Goulder, P., Cresswell, P., Elliott, T., Sette, A., Carlson, J., and Carrington, M.

Oct 9, 2020 Clin Infect Dis

Interferon-gama release assay for accurate detection of SARS-CoV-2 T cell response

Murugesan K, Jagannathan P, Pham TD, Pandey S, Bonilla HF, Jacobson K, Parsonnet J, Andrews JR, Weiskopf D, Sette A, Pinsky BA, Singh U, Banaei N